Cargando…

S100A11 Overexpression Promotes Fatty Liver Diseases via Increased Autophagy?

Detalles Bibliográficos
Autores principales:	Ni, Hong-Min, Chao, Xiaojuan, Ding, Wen-Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900834/ https://www.ncbi.nlm.nih.gov/pubmed/33290740 http://dx.doi.org/10.1016/j.jcmgh.2020.11.013

Ejemplares similares

Impaired Rab7 and dynamin2 block fat turnover by autophagy in alcoholic fatty livers
por: Li, Yuan, et al.
Publicado: (2017)

S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis
por: Zhang, Linqiang, et al.
Publicado: (2020)

Autophagy and liver cancer
por: Chao, Xiaojuan, et al.
Publicado: (2020)

Linking of Senescence to Autophagy Deficiency in Chronic Liver Disease
por: Ma, Xiaowen, et al.
Publicado: (2022)

Autophagy impairment in liver CD11c(+) cells promotes non-alcoholic fatty liver disease through production of IL-23
por: Galle-Treger, Lauriane, et al.
Publicado: (2022)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
por: Sinn, Dong Hyun, et al.
Publicado: (2014)

Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice
por: Cho, Ye Eun, et al.
Publicado: (2023)

S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma
por: Delangre, Etienne, et al.
Publicado: (2022)

S100A8 promotes chemoresistance via augmenting autophagy in B-cell lymphoma cells
por: Zhang, Li, et al.
Publicado: (2021)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy
por: Zhang, Xinxu, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Curing Fatty Liver with Oxysterols?
por: Uehara, Kahealani, et al.
Publicado: (2022)

Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver()
por: Ni, Hong-Min, et al.
Publicado: (2013)

S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF‐κB positive feedback loop
por: Tu, Yiming, et al.
Publicado: (2019)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Role of Autophagy in Ehrlichia-Induced Liver Injury
por: Sharma, Aditya Kumar, et al.
Publicado: (2023)

The Overexpression of Scaffolding Protein NEDD9 Promotes Migration and Invasion in Cervical Cancer via Tyrosine Phosphorylated FAK and SRC
por: Sima, Ni, et al.
Publicado: (2013)

S100a16 Deficiency Prevents Alcohol-induced Fatty Liver Injury via Inducing MANF Expression in Mice
por: Wang, Dan, et al.
Publicado: (2023)

Autophagy and Non-Alcoholic Fatty Liver Disease
por: Lavallard, Vanessa J., et al.
Publicado: (2014)

Diet and Exercise in the Treatment of Fatty Liver
por: Magkos, Faidon, et al.
Publicado: (2012)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Treating fatty liver and insulin resistance
por: Perry, Rachel J., et al.
Publicado: (2013)

Glutamine, fatty liver disease and aging
por: Simón, Jorge, et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]
Publicado: (2021)

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
por: Jang, Hyun-Jun, et al.
Publicado: (2023)

Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy In Vivo and In Vitro
por: Su, Yanze, et al.
Publicado: (2022)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Calpain 2-mediated autophagy defect increases susceptibility of fatty livers to ischemia–reperfusion injury
por: Zhao, Q, et al.
Publicado: (2016)

AMPK activates DAPK2 to promote autophagy
por: Shiloh, Ruth, et al.
Publicado: (2018)

Andrographolide protects mouse astrocytes against hypoxia injury by promoting autophagy and S100B expression
por: Du, Juan, et al.
Publicado: (2018)

Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

Fatty Liver Disease: Metabolic, Genetic, or Both?
por: Zoller, Heinz, et al.
Publicado: (2020)

Blowing Away Fatty Liver: Mission Impossible?
por: McLean, Anna E. B., et al.
Publicado: (2021)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

The Role of Carnitine Orotate Complex in Fatty Liver
por: Yi, Hyon-Seung
Publicado: (2021)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

100 Already?
por: Negrin, Robert S.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e2b9hv2rrgth6ecd8rtjavu48m